# Renal Cell Carcinoma: Developing Drugs and Biologics for Adjuvant Treatment:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/renal-cell-carcinoma-developing-drugs-and-biologics-for-adjuvant-treatment-guidance-for-industry/db30c852-ed7b-4054-8906-3aadd3851179

> FDA guidance document: Renal Cell Carcinoma: Developing Drugs and Biologics for Adjuvant Treatment:  Guidance for Industry. Issue date: June 27, 2022. Get complete insights and analysis.

---

## Details

- Title: Renal Cell Carcinoma: Developing Drugs and Biologics for Adjuvant Treatment:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Office of the Commissioner
- Office URL: /offices/office-of-the-commissioner/79483979-9582-427f-ac3d-46c715811424
- Issue Date: 2022-06-27
- Comment Close Date: 2020-12-01
- Last Changed: 2022-06-28
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2020-D-1496">FDA-2020-D-1496</a>

## Related Documents

- [Premenopausal Women with Breast Cancer: Developing Drugs for Treatment:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/premenopausal-women-with-breast-cancer-developing-drugs-for-treatment-guidance-for-industry/03f0e242-74ab-4a8e-b4b3-5d5c1d720852)
- [Bladder Cancer: Developing Drugs and Biologics for Adjuvant Treatment:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/bladder-cancer-developing-drugs-and-biologics-for-adjuvant-treatment-guidance-for-industry/b3fd959c-72c5-4e86-a4a9-5fa31d0ce7b7)
- [Male Breast Cancer: Developing Drugs for Treatment:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/male-breast-cancer-developing-drugs-for-treatment-guidance-for-industry/76829c69-4547-4b3d-bde5-9bf7ef4e1490)